Heat Biologics Will Acquire Biodefense Company Elusys Therapeutics | North Carolina Biotechnology Center

Morrisville-based Heat Biologics has signed a definitive merger agreement to acquire Elusys Therapeutics, a biodefense company that makes a treatment for anthrax, a deadly infectious disease potentially spread by bioterrorism or biowarfare.

Related Keywords

United States ,Canada ,Morrisville ,North Carolina ,United Kingdom ,American ,David Lasseter ,Jeff Wolf ,Elizabeth Posillico ,Skunkworx Bio ,Exchange Commission ,Biotech Center ,University Of Miami ,Carolina Biotechnology Center Landing Pad ,Nasdaq ,Us Strategic National Stockpile ,Morrisville Based Heat Biologics ,Elusys Therapeutics ,National Stockpile ,Biothreat Advisory Board ,Biothreat Advisory ,North Carolina Biotechnology Center ,Landing Pad ,